Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
4(57%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
1
14%
Ph phase_3
1
14%
Ph phase_1
2
29%
Ph not_applicable
3
43%

Phase Distribution

2

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
2(28.6%)
Phase 2Efficacy & side effects
1(14.3%)
Phase 3Large-scale testing
1(14.3%)
N/ANon-phased studies
3(42.9%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

7

all time

Status Distribution
Active(5)
Completed(1)
Other(1)

Detailed Status

Active, not recruiting2
Recruiting2
unknown1
Completed1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
4
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (28.6%)
Phase 21 (14.3%)
Phase 31 (14.3%)
N/A3 (42.9%)

Trials by Status

active_not_recruiting229%
unknown114%
completed114%
enrolling_by_invitation114%
recruiting229%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
7